Key opinion leaders - a critical perspective.

Key opinion leaders - a critical perspective.
复制标题

关键意见领袖-一个关键的角度来看。

DOI:
10.1038/s41584-020-00539-1
复制
发表时间:
2021-03
期刊:
Nature reviews. Rheumatology
影响因子:
--
通讯作者:
Schett G
Schett G
中科院分区:
其他
文献类型:
--
作者:
Scher JU;Schett G

文献摘要

参考文献

被引文献

相似文献

过去几十年来,风湿病学领域取得了巨大进展,历史上是由公共资助的学术创新者领导的,但最近制药行业更多地参与其中。这种资源的转变创造了一种复杂的医疗界再投资新模式,其中绝大多数私人资金被重新定向,通过“关键意见领袖”影响从业人员的处方行为,其主要目的是增强和维持利润,而不是创新和批判性思维,而且往往以牺牲与科学家(即基础研究人员和转化研究人员)的合作关系和学术合作为代价。这种新的认识带来了多种机会来重新思考维持该领域长期关键研究的方法,最终最大化投资回报:造福患者和社会的科学知识。这些战略的核心应该是重新平衡学术界与工业界的伙伴关系,转向学术研究和“创新和知识领袖”的参与,而不是主要是关键意见领袖。在本文中,作者批判性地评价了当前基于观点的学术界与工业界互动的模式,并主张重新调整伙伴关系,以促进创新和知识。
Enormous progress has been made in the field of rheumatology in the past several decades, historically led by publicly funded academic innovators but in more recent times with much greater involvement of the pharmaceutical industry. This shift in resources has created a complex new model for reinvestment in the medical community in which the vast majority of private funds are redirected towards influencing the prescription behaviour of practitioners through ‘key opinion leaders’, with the main purpose of enhancing and perpetuating profit rather than innovation and critical thinking, and often at the expense of partnerships with scientists (that is, basic and translational researchers) and academic collaborations. This new episteme brings multiple opportunities to rethink approaches to sustaining long-term critical research in the field, ultimately maximizing the return on investment: scientific knowledge for the benefit of patients and society. Central to such strategies should be the rebalancing of academia–industry partnerships towards academic research and the involvement of ‘innovation and knowledge leaders’, rather than mostly key opinion leaders. In this article, the authors critically appraise the current model of opinion-based academia–industry interactions, and advocate for a realignment towards partnerships that foster innovation and knowledge.
DOI: 10.1016/s1074-7613(00)00070-4
发表时间: 2000-11-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Oppmann, B;Lesley, R;Kastelein, RA
通讯作者: Kastelein, RA
DOI: 10.1038/s41586-019-1471-1
发表时间: 2019-08-29
期刊: NATURE
影响因子: 64.8
作者:
Culemann, Stephan;Grueneboom, Anika;Kroenke, Gerhard
通讯作者: Kroenke, Gerhard
DOI: 10.1093/restud/rdy034
发表时间: 2019-01-01
影响因子: 5.8
作者:
Azoulay, Pierre;Zivin, Joshua S. Graff;Sampat, Bhaven N.
通讯作者: Sampat, Bhaven N.
DOI: 10.1093/rheumatology/key368
发表时间: 2019-05-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Khan, Nasim Ahmed;Nguyen, Chau L.;Torralba, Karina D.
通讯作者: Torralba, Karina D.
DOI: 10.1111/j.1467-6435.2011.00519.x
发表时间: 2011-11-01
期刊: KYKLOS
影响因子: 1.9
作者:
Hottenrott, Hanna;Thorwarth, Susanne
通讯作者: Thorwarth, Susanne